Sarcoma  >>  tasisulam (LY573636)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tasisulam (LY573636) / Eli Lilly
NCT00490451 / 2007-001402-24: A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma

Completed
2
101
Europe, US, RoW
LY573636-sodium, Tasisulam
Eli Lilly and Company
Sarcoma, Soft Tissue
02/10
02/10

Download Options